In breast, bladder, and prostate cancer models, ZKSCAN3 has demonstrated an enhancing effect on cancer cell vitality, migration, invasiveness, and tumorigenicity [10,32,40]. Here, ZKSCAN3 is linked to prostate carcinoma.